Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA

Joanna Nizioł1, Vincent Bonifay2, Krzysztof Ossoliński3

  • 1Faculty of Chemistry, Rzeszow University of Technology, 35-959, Rzeszow, Poland. jniziol@prz.edu.pl.

Insights

Researchers identified potential biomarkers for clear cell renal cell carcinoma (ccRCC) by analyzing kidney tissue and urine. Elevated levels of specific carnitines and norepinephrine sulfate in cancer patients may aid in early detection of this kidney cancer.

Area of Science:

  • Metabolomics
  • Biomarker Discovery
  • Urology
  • Oncology

Background:

  • Renal cell carcinoma (RCC) is a significant cause of cancer-related mortality.
  • Current clinical management of kidney cancer lacks validated tissue biomarkers.
  • The need for reliable biomarkers for early diagnosis and treatment monitoring of ccRCC is critical.

Purpose of the Study:

  • To identify potential urinary and tissue biomarkers for clear cell renal cell carcinoma (ccRCC).
  • To investigate metabolic differences between cancerous and normal kidney tissues and associated urine samples.
  • To discover novel up- and downregulated compounds indicative of renal cancer.

Main Methods:

  • Non-targeted metabolomic analysis of paired surgically removed renal cancer and normal tissue.
  • Analysis of urine samples from ccRCC patients and healthy controls.
  • Liquid chromatography/high-resolution mass spectrometry (LC-HRMS) for compound identification.

Main Results:

  • Hydroxybutyrylcarnitine, decanoylcarnitine, propanoylcarnitine, carnitine, dodecanoylcarnitine, and norepinephrine sulfate were significantly elevated in ccRCC tissues and patient urine.
  • Riboflavin and N-acetylaspartylglutamate (NAAG) were found at higher concentrations in normal kidney tissue and healthy urine.
  • These identified compounds show potential as diagnostic biomarkers for ccRCC.

Conclusions:

  • The study successfully identified several candidate biomarkers for ccRCC.
  • Metabolomic profiling of tissue and urine offers a promising approach for kidney cancer biomarker discovery.
  • Further validation is required to establish these compounds as reliable clinical biomarkers for renal cell carcinoma.

Related Concept Videos

Filtration and Urine Formation01:32

Filtration and Urine Formation

The function of the kidneys is to filter, reabsorb, secrete, and excrete. Every day the kidneys filter nearly 180 liters of blood, initially removing water and solutes but ultimately returning nearly all filtrates into circulation with the help of osmoregulatory hormones. This process removes wastes and toxins but is also crucial to maintain water and electrolyte levels. Most of these functions are performed by the tiny but numerous nephrons contained within the kidneys.
53.9K
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
1.3K
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
1.6K
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
606
High-Resolution Mass Spectrometry (HRMS)01:15

High-Resolution Mass Spectrometry (HRMS)

The resolution of a mass spectrometer depends on the efficiency of separating ions with different ion masses. The mass of an atom is approximated to the sum of the masses of protons and neutrons inside, considering the masses of protons and neutrons as equal. However, the masses of the proton (1.6726 × 10−24 g) and neutron (1.6749 × 10−24 g) are not truly equal. There is a minor error in the expression of atomic masses relative to the simplest atom of hydrogen. For...
2.6K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
457